Earnings Growth & Price Strength Make Palantir Technologies Inc. (PLTR) a Stock to Watch

Zacks Investment Research highlights its 'Focus List,' a curated portfolio of 50 stocks selected based on proprietary earnings estimate revisions and the Zacks Rank, aiming for long-term market outperformance. The strategy has demonstrated significant historical success, with the Focus List achieving a cumulative return of 2,519.23% against the S&P 500's 854.95% from February 1996 to March 2021, and a 13.85% gain in 2020 compared to the S&P's 9.38%. A recent addition, Palantir Technologies (PLTR), exemplifies this, with its shares surging 282.62% since being added to the list in March 2024.

Analysis

The Zacks Focus List strategy, which identifies 50 stocks for potential long-term outperformance based on positive earnings estimate revisions, has demonstrated significant historical success, delivering a cumulative return of 2,519.23% from February 1996 to March 2021, substantially outpacing the S&P 500's 854.95% over the same period. Palantir Technologies (PLTR) is presented as a recent case study, having appreciated 282.62% to $93.78 per share since its addition to the list on March 26, 2024. Despite this strong performance and an analyst expectation for 34.2% earnings growth in the current fiscal year, several signals warrant careful consideration. PLTR's current Zacks Rank is #3 (Hold), a downgrade from the #1 (Strong Buy) or #2 (Buy) status required for inclusion, suggesting a shift in its near-term outlook. Furthermore, while one analyst revised fiscal 2025 earnings estimates upward in the last 60 days, the Zacks Consensus Estimate remained unchanged at $0.55, indicating the single revision was not material enough to shift broader sentiment.

Key Decisions for Investors

• Investors should recognize that PLTR's 282.62% price increase since its inclusion on the Focus List may have already captured significant upside, a view supported by its current Zacks Rank of #3 (Hold).
• Given the static consensus earnings estimate despite an upward revision, it is prudent to monitor for broader positive revisions from multiple analysts before considering a new or expanded position in PLTR.
• The core takeaway is the demonstrated efficacy of a strategy centered on earnings estimate revisions, suggesting investors could use this as a screening factor to identify potential opportunities rather than focusing solely on PLTR, which has already experienced a substantial run-up.